FI943100A0 - Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina - Google Patents

Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina

Info

Publication number
FI943100A0
FI943100A0 FI943100A FI943100A FI943100A0 FI 943100 A0 FI943100 A0 FI 943100A0 FI 943100 A FI943100 A FI 943100A FI 943100 A FI943100 A FI 943100A FI 943100 A0 FI943100 A0 FI 943100A0
Authority
FI
Finland
Prior art keywords
cogenic
anticancer agents
ansamycin derivatives
ansamycin
derivatives
Prior art date
Application number
FI943100A
Other languages
English (en)
Swedish (sv)
Other versions
FI943100A (fi
Inventor
Randall James Gallaschun
Mikel Paul Moyer
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI943100A0 publication Critical patent/FI943100A0/fi
Publication of FI943100A publication Critical patent/FI943100A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D225/00Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI943100A 1993-06-29 1994-06-28 Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina FI943100A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8506593A 1993-06-29 1993-06-29

Publications (2)

Publication Number Publication Date
FI943100A0 true FI943100A0 (fi) 1994-06-28
FI943100A FI943100A (fi) 1994-12-30

Family

ID=22189242

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943100A FI943100A (fi) 1993-06-29 1994-06-28 Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina

Country Status (5)

Country Link
EP (1) EP0706516A1 (fi)
JP (1) JP2794342B2 (fi)
CA (1) CA2166320A1 (fi)
FI (1) FI943100A (fi)
WO (1) WO1995001342A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002520369A (ja) 1998-07-17 2002-07-09 アメリカ合衆国 水溶性薬剤およびその製造方法
AU769235B2 (en) * 1999-04-09 2004-01-22 Sloan-Kettering Institute For Cancer Research Methods and compositions for degradation and/or inhibition of her-family tyrosine kinases
AU2002217866A1 (en) * 2000-11-06 2002-05-15 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Geldanamycin derivatives useful for the treatment of cancer
SI21369A (sl) * 2001-03-30 2004-06-30 The United States Of America, Represented By The Secretary, Geldanamicinski derivat in postopek zdravljenja raka z uporabo le-tega
WO2003013430A2 (en) * 2001-08-06 2003-02-20 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1923061A1 (en) 2001-09-24 2008-05-21 Conforma Therapeutic Corporation Process for preparing 17-Allyl amino geldanamycin (17-AAG) and other ansamycins
DE60225307T2 (de) * 2001-09-24 2009-03-19 Conforma Therapeutics Corp., San Diego Verfahren zur herstellung von 17-allyl-amino-geldanamycin (17-aag) und anderer ansamycine
ATE433961T1 (de) 2002-02-08 2009-07-15 Conforma Therapeutics Corp Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
AU2003277299B2 (en) * 2002-04-10 2009-12-10 Conforma Therapeutics Corporation Drug formulations having long and medium chain triglycerides
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
CA2545457A1 (en) 2003-11-12 2005-06-23 Kosan Biosciences, Inc. 11-o-methylgeldanamycin compounds
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
EP2492261B1 (en) 2003-12-23 2015-02-18 Infinity Discovery, Inc. Analogs of benzoquinone-containing ansamycins for the treatment of cancer
PE20081506A1 (es) * 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
WO2010045442A1 (en) 2008-10-15 2010-04-22 Infinity Discovery, Inc. Ansamycin hydroquinone compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3595955A (en) * 1969-03-26 1971-07-27 Upjohn Co Geldanamycin and process for producing same
US3987035A (en) * 1974-04-05 1976-10-19 University Of Illinois Foundation Biologically active compounds
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
JPH06510913A (ja) * 1992-01-06 1994-12-08 フアイザー・インコーポレイテツド 4,5‐ジヒドロゲルダナマイシン及びそのヒドロキノンの製造及び使用

Also Published As

Publication number Publication date
JP2794342B2 (ja) 1998-09-03
FI943100A (fi) 1994-12-30
WO1995001342A1 (en) 1995-01-12
CA2166320A1 (en) 1995-01-12
JPH08506356A (ja) 1996-07-09
EP0706516A1 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
FI973471A (fi) Pyratsol-4-yylibentsoyylijohdoksia ja niiden käyttö herbisideinä
FI935309A0 (fi) Vattenloesliga manganpartiklar som medel foer foerstaerkande av magnetisk resonanskontrast
FI943100A0 (fi) Ansamysiinijohdannaisia antionkogeenisina ja syövänvastaisina aineina
NO20002162L (no) Tienopyrimidin- og tienopyridinderivater nyttige som anticancer midler
FI934373A (fi) Fabrikationsprocess av komposittraod och kompositprodukter som faotts avnaemnda traoden
FI930489A (fi) Vattenloesliga sulfoalkylhydroxialkylderivat av cellulosa och anvaendning av dem i gips- och cementhaltiga massor
DK0551048T3 (da) 2-Imidazon-5-on- og 2-imidazolin-5-thion-derivater som fungicider
NO20000366D0 (no) O-substituerte hydroksycoumaranon-derivater som anti-tumor- og antimetastase-midler
FI935767A0 (fi) Foerfarande och anordning foer centrering av en stock och foer tillfoeringav en stock som skall centreras
FI964936A0 (fi) Bentsopyraaneja ja niiden käyttö terapeuttisina aineina
FI931701A (fi) Derivat av faktor som inhiberar fettbildning, framstaellning och anvaendning
FI961977A0 (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
NO980009D0 (no) Triazolin og isokazolin bis-oksim derivater og deres anvendelse som pesticider
DE69611758D1 (de) N-1-carbocylalkyl derivate von lsd
FI971462A0 (fi) Bentsisoksatsolijohdannaisia ja niitä sisältäviä torjuntaainekoostumuksia
FI953106A (fi) Difuoripentapeptidijohdannaiset anti-inflammatorisina aineina
EE03614B1 (et) Pürasool-4-üül-bensoüüli derivaadid ja nende kasutamine herbitsiididena
FI922472A0 (fi) Gingerol- och gingerdiolderivat som hypokolesterolemiska och antiaterosklerostiska medel.
FI955335A0 (fi) Bicyklopolyazamakrocyklofosfonsyror, komplex och konjugat daerav foer anvaendning som kontrastmedel och foerfarande foer framstaellning av dessa
DK0660715T3 (da) Carbostyrilderivater som antiarytmiske midler
FI931178A0 (fi) Foerfarande och medel foer oeppnande av kuvert
NO951299D0 (no) Polyaminderivater som anti-cytomegalovirale midler
FI933784A0 (fi) Foerfarande och medel foer att uppiva vaettendrag och att foerbaettra fodrets kvalitet
FI934005A0 (fi) Foerfarande foer visning av parkeringstid i en betalanordning foer parkering och en betalanordning foer parkering som visar parkeringstid
FI650U1 (fi) Byggnad som omfattar flera vaoningar och som bestaor av moduler